

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 6.41625798 |
| 2 | ribosomal small subunit biogenesis (GO:0042274) | 5.30665588 |
| 3 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 5.17230900 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.09043489 |
| 5 | viral transcription (GO:0019083) | 4.93180991 |
| 6 | chaperone-mediated protein transport (GO:0072321) | 4.75715024 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 4.73060537 |
| 8 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.71145646 |
| 9 | ATP synthesis coupled proton transport (GO:0015986) | 4.71145646 |
| 10 | translational termination (GO:0006415) | 4.58092260 |
| 11 | protein maturation by protein folding (GO:0022417) | 4.54269752 |
| 12 | regulation of mitochondrial translation (GO:0070129) | 4.49219512 |
| 13 | respiratory electron transport chain (GO:0022904) | 4.38832015 |
| 14 | GDP-mannose metabolic process (GO:0019673) | 4.34337977 |
| 15 | translational elongation (GO:0006414) | 4.33528914 |
| 16 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.29346902 |
| 17 | electron transport chain (GO:0022900) | 4.29228463 |
| 18 | deoxyribose phosphate biosynthetic process (GO:0046385) | 4.28678195 |
| 19 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 4.28678195 |
| 20 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.23027186 |
| 21 | guanosine-containing compound biosynthetic process (GO:1901070) | 4.21612368 |
| 22 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.17872925 |
| 23 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.16301820 |
| 24 | protein targeting to mitochondrion (GO:0006626) | 4.13429838 |
| 25 | oxidative phosphorylation (GO:0006119) | 4.08596230 |
| 26 | metallo-sulfur cluster assembly (GO:0031163) | 4.07251023 |
| 27 | iron-sulfur cluster assembly (GO:0016226) | 4.07251023 |
| 28 | protein targeting to ER (GO:0045047) | 4.07046220 |
| 29 | cotranslational protein targeting to membrane (GO:0006613) | 4.06671070 |
| 30 | deoxyribonucleotide catabolic process (GO:0009264) | 4.05544372 |
| 31 | base-excision repair, AP site formation (GO:0006285) | 4.03923989 |
| 32 | protein localization to endoplasmic reticulum (GO:0070972) | 3.98027506 |
| 33 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.96984709 |
| 34 | NADH dehydrogenase complex assembly (GO:0010257) | 3.96984709 |
| 35 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.96984709 |
| 36 | protein complex biogenesis (GO:0070271) | 3.91415865 |
| 37 | pseudouridine synthesis (GO:0001522) | 3.90837871 |
| 38 | establishment of protein localization to mitochondrion (GO:0072655) | 3.88016523 |
| 39 | viral life cycle (GO:0019058) | 3.86803176 |
| 40 | deoxyribose phosphate catabolic process (GO:0046386) | 3.85743976 |
| 41 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.83525712 |
| 42 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.74855917 |
| 43 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.73105269 |
| 44 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.72034945 |
| 45 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.67495912 |
| 46 | GTP biosynthetic process (GO:0006183) | 3.66639283 |
| 47 | maturation of SSU-rRNA (GO:0030490) | 3.64913360 |
| 48 | cellular protein complex disassembly (GO:0043624) | 3.63592896 |
| 49 | proteasome assembly (GO:0043248) | 3.62511900 |
| 50 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.62310135 |
| 51 | protein localization to mitochondrion (GO:0070585) | 3.61515779 |
| 52 | negative regulation of B cell apoptotic process (GO:0002903) | 3.61506673 |
| 53 | UTP biosynthetic process (GO:0006228) | 3.60817253 |
| 54 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.59240922 |
| 55 | GMP metabolic process (GO:0046037) | 3.58992763 |
| 56 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.57730776 |
| 57 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.56342956 |
| 58 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.55592433 |
| 59 | purine nucleotide salvage (GO:0032261) | 3.55252992 |
| 60 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.50581990 |
| 61 | translation (GO:0006412) | 3.46259481 |
| 62 | translational initiation (GO:0006413) | 3.44438610 |
| 63 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.43505635 |
| 64 | cellular component biogenesis (GO:0044085) | 3.42381294 |
| 65 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.39970113 |
| 66 | nucleotide salvage (GO:0043173) | 3.35394313 |
| 67 | ribosomal large subunit biogenesis (GO:0042273) | 3.34976697 |
| 68 | deoxyribose phosphate metabolic process (GO:0019692) | 3.34359644 |
| 69 | CTP metabolic process (GO:0046036) | 3.33742331 |
| 70 | CTP biosynthetic process (GO:0006241) | 3.33742331 |
| 71 | protein complex disassembly (GO:0043241) | 3.32922188 |
| 72 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.31365140 |
| 73 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.29243971 |
| 74 | termination of RNA polymerase III transcription (GO:0006386) | 3.27664855 |
| 75 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.27664855 |
| 76 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.25211679 |
| 77 | UTP metabolic process (GO:0046051) | 3.23961716 |
| 78 | rRNA modification (GO:0000154) | 3.22175342 |
| 79 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.19587482 |
| 80 | mitochondrial transport (GO:0006839) | 3.13741867 |
| 81 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.12105602 |
| 82 | negative regulation of ligase activity (GO:0051352) | 3.12105602 |
| 83 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.11606011 |
| 84 | macromolecular complex disassembly (GO:0032984) | 3.11435390 |
| 85 | DNA strand elongation (GO:0022616) | 3.10871242 |
| 86 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.10141803 |
| 87 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.08586177 |
| 88 | histone arginine methylation (GO:0034969) | 3.07785265 |
| 89 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.06164315 |
| 90 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.05758540 |
| 91 | mitotic nuclear envelope reassembly (GO:0007084) | 3.03662585 |
| 92 | nuclear envelope reassembly (GO:0031468) | 3.03662585 |
| 93 | peptidyl-histidine modification (GO:0018202) | 3.00907074 |
| 94 | formation of translation preinitiation complex (GO:0001731) | 2.99784157 |
| 95 | viral mRNA export from host cell nucleus (GO:0046784) | 2.97266450 |
| 96 | protein targeting to membrane (GO:0006612) | 2.94633594 |
| 97 | ATP biosynthetic process (GO:0006754) | 2.94227082 |
| 98 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.93112020 |
| 99 | proline biosynthetic process (GO:0006561) | 2.92833752 |
| 100 | cytochrome complex assembly (GO:0017004) | 2.92806088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.61354397 |
| 2 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.14278212 |
| 3 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.13343154 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.07298234 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.01590023 |
| 6 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.79290611 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.71874972 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.57054444 |
| 9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.46593777 |
| 10 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.36053394 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.35357715 |
| 12 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.32540109 |
| 13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.30842971 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.28659549 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.22790404 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.20045894 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18775214 |
| 18 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.09282058 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.05250425 |
| 20 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.01529695 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.00108928 |
| 22 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.97910524 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.97897215 |
| 24 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.91765081 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.89402957 |
| 26 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.88345821 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.88208059 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.83495762 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.79391638 |
| 30 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.78692617 |
| 31 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.76764844 |
| 32 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.75097680 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72727600 |
| 34 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.72339121 |
| 35 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.70676535 |
| 36 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.67867025 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.66495082 |
| 38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.65384235 |
| 39 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.62148203 |
| 40 | * P68_20966046_ChIP-Seq_HELA_Human | 1.60996722 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58435322 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.55386859 |
| 43 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.54663798 |
| 44 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.52951635 |
| 45 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.51134566 |
| 46 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.50212455 |
| 47 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.49938570 |
| 48 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.48339570 |
| 49 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.46206472 |
| 50 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.44950651 |
| 51 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.42489610 |
| 52 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.40737640 |
| 53 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.40662889 |
| 54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.39582618 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39495531 |
| 56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.38605370 |
| 57 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.36498420 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35711963 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35271934 |
| 60 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.32343909 |
| 61 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.31718070 |
| 62 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30331903 |
| 63 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.29369335 |
| 64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28885199 |
| 65 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28216192 |
| 66 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.27482937 |
| 67 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.25674914 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24339445 |
| 69 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23753629 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.21426127 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19803094 |
| 72 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19223891 |
| 73 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.16616922 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14767731 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14716266 |
| 76 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14352001 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.11705032 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11115271 |
| 79 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10793648 |
| 80 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.10659614 |
| 81 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.10276526 |
| 82 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.10171830 |
| 83 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08906756 |
| 84 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.08039559 |
| 85 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.07114846 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06501895 |
| 87 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06489881 |
| 88 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.05877600 |
| 89 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05768743 |
| 90 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.05615383 |
| 91 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.04399197 |
| 92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.04096090 |
| 93 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.04029918 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.04000544 |
| 95 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.03654052 |
| 96 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03337668 |
| 97 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.03059502 |
| 98 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02061408 |
| 99 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.00935903 |
| 100 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.00332935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.00154366 |
| 2 | MP0005451_abnormal_body_composition | 3.67089610 |
| 3 | MP0006036_abnormal_mitochondrial_physio | 3.51402509 |
| 4 | MP0003186_abnormal_redox_activity | 2.87041428 |
| 5 | MP0009379_abnormal_foot_pigmentation | 2.75097266 |
| 6 | MP0003786_premature_aging | 2.73798771 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.68075561 |
| 8 | MP0008058_abnormal_DNA_repair | 2.63286247 |
| 9 | MP0003693_abnormal_embryo_hatching | 2.55151970 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.53799555 |
| 11 | MP0006035_abnormal_mitochondrial_morpho | 2.50164791 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.34615953 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.24974544 |
| 14 | MP0008932_abnormal_embryonic_tissue | 2.19237892 |
| 15 | MP0003077_abnormal_cell_cycle | 2.14761680 |
| 16 | MP0001905_abnormal_dopamine_level | 2.10184860 |
| 17 | MP0009278_abnormal_bone_marrow | 1.95773587 |
| 18 | MP0004957_abnormal_blastocyst_morpholog | 1.92665397 |
| 19 | MP0004858_abnormal_nervous_system | 1.89838419 |
| 20 | MP0005670_abnormal_white_adipose | 1.84217793 |
| 21 | MP0008007_abnormal_cellular_replicative | 1.84093039 |
| 22 | MP0002736_abnormal_nociception_after | 1.84032975 |
| 23 | MP0004859_abnormal_synaptic_plasticity | 1.74840643 |
| 24 | MP0000358_abnormal_cell_content/ | 1.73165366 |
| 25 | MP0003123_paternal_imprinting | 1.71838154 |
| 26 | MP0001968_abnormal_touch/_nociception | 1.64850091 |
| 27 | MP0008260_abnormal_autophagy | 1.59454278 |
| 28 | MP0000750_abnormal_muscle_regeneration | 1.51647314 |
| 29 | MP0000678_abnormal_parathyroid_gland | 1.49262834 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.49167649 |
| 31 | MP0002822_catalepsy | 1.46943885 |
| 32 | MP0001764_abnormal_homeostasis | 1.46327333 |
| 33 | MP0008995_early_reproductive_senescence | 1.43841302 |
| 34 | MP0005501_abnormal_skin_physiology | 1.42604293 |
| 35 | MP0000372_irregular_coat_pigmentation | 1.40082541 |
| 36 | MP0002163_abnormal_gland_morphology | 1.39717294 |
| 37 | MP0004147_increased_porphyrin_level | 1.38339476 |
| 38 | MP0001348_abnormal_lacrimal_gland | 1.36196390 |
| 39 | MP0000313_abnormal_cell_death | 1.34734094 |
| 40 | MP0002019_abnormal_tumor_incidence | 1.33629902 |
| 41 | MP0002132_abnormal_respiratory_system | 1.29397961 |
| 42 | MP0010030_abnormal_orbit_morphology | 1.25452914 |
| 43 | MP0005083_abnormal_biliary_tract | 1.24805633 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.24113092 |
| 45 | MP0000490_abnormal_crypts_of | 1.20147107 |
| 46 | MP0000681_abnormal_thyroid_gland | 1.19287129 |
| 47 | MP0001529_abnormal_vocalization | 1.17116124 |
| 48 | MP0001346_abnormal_lacrimal_gland | 1.16883254 |
| 49 | MP0001661_extended_life_span | 1.14973556 |
| 50 | MP0005330_cardiomyopathy | 1.13604040 |
| 51 | MP0000858_altered_metastatic_potential | 1.13203376 |
| 52 | MP0002249_abnormal_larynx_morphology | 1.11435824 |
| 53 | MP0000350_abnormal_cell_proliferation | 1.10351316 |
| 54 | MP0001873_stomach_inflammation | 1.10269956 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.04516642 |
| 56 | MP0003315_abnormal_perineum_morphology | 1.04095607 |
| 57 | MP0002398_abnormal_bone_marrow | 1.03655616 |
| 58 | MP0001188_hyperpigmentation | 1.02298554 |
| 59 | MP0001853_heart_inflammation | 0.99013268 |
| 60 | MP0002653_abnormal_ependyma_morphology | 0.98284850 |
| 61 | MP0002429_abnormal_blood_cell | 0.96633213 |
| 62 | MP0000703_abnormal_thymus_morphology | 0.95366167 |
| 63 | MP0000003_abnormal_adipose_tissue | 0.92767727 |
| 64 | MP0002722_abnormal_immune_system | 0.92015683 |
| 65 | MP0001727_abnormal_embryo_implantation | 0.92004426 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 0.91446802 |
| 67 | MP0001545_abnormal_hematopoietic_system | 0.91446802 |
| 68 | MP0004233_abnormal_muscle_weight | 0.91274739 |
| 69 | MP0005666_abnormal_adipose_tissue | 0.86569245 |
| 70 | MP0005464_abnormal_platelet_physiology | 0.83934520 |
| 71 | MP0002234_abnormal_pharynx_morphology | 0.83719143 |
| 72 | MP0005671_abnormal_response_to | 0.83402823 |
| 73 | MP0002080_prenatal_lethality | 0.81071977 |
| 74 | MP0003718_maternal_effect | 0.80500108 |
| 75 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80128598 |
| 76 | MP0008873_increased_physiological_sensi | 0.78847330 |
| 77 | MP0008789_abnormal_olfactory_epithelium | 0.78139649 |
| 78 | MP0000716_abnormal_immune_system | 0.76633970 |
| 79 | MP0005375_adipose_tissue_phenotype | 0.75898291 |
| 80 | MP0002148_abnormal_hypersensitivity_rea | 0.74977244 |
| 81 | MP0000689_abnormal_spleen_morphology | 0.74203941 |
| 82 | MP0000747_muscle_weakness | 0.73789576 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 0.73724497 |
| 84 | MP0001819_abnormal_immune_cell | 0.71660105 |
| 85 | MP0001881_abnormal_mammary_gland | 0.70519722 |
| 86 | MP0001730_embryonic_growth_arrest | 0.70510402 |
| 87 | MP0005384_cellular_phenotype | 0.69795246 |
| 88 | MP0002420_abnormal_adaptive_immunity | 0.69625140 |
| 89 | MP0008874_decreased_physiological_sensi | 0.68529998 |
| 90 | MP0003880_abnormal_central_pattern | 0.67512611 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.67465881 |
| 92 | MP0000343_altered_response_to | 0.67079446 |
| 93 | MP0008872_abnormal_physiological_respon | 0.67069855 |
| 94 | MP0002735_abnormal_chemical_nociception | 0.65380313 |
| 95 | MP0003436_decreased_susceptibility_to | 0.63012951 |
| 96 | MP0000759_abnormal_skeletal_muscle | 0.62711787 |
| 97 | MP0003075_altered_response_to | 0.62647276 |
| 98 | MP0005025_abnormal_response_to | 0.61279526 |
| 99 | MP0003137_abnormal_impulse_conducting | 0.60524093 |
| 100 | MP0002970_abnormal_white_adipose | 0.58897471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.43618664 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 5.24488670 |
| 3 | Mitochondrial inheritance (HP:0001427) | 5.00090196 |
| 4 | Hepatocellular necrosis (HP:0001404) | 4.96217184 |
| 5 | Acute encephalopathy (HP:0006846) | 4.74471571 |
| 6 | Hepatic necrosis (HP:0002605) | 4.41445460 |
| 7 | Increased CSF lactate (HP:0002490) | 4.39447879 |
| 8 | Increased intramyocellular lipid droplets (HP:0012240) | 4.39251170 |
| 9 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.36262926 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.36262926 |
| 11 | Increased muscle lipid content (HP:0009058) | 4.23083763 |
| 12 | Progressive macrocephaly (HP:0004481) | 3.96750556 |
| 13 | Abnormal number of erythroid precursors (HP:0012131) | 3.70270137 |
| 14 | Testicular atrophy (HP:0000029) | 3.67003966 |
| 15 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.55437567 |
| 16 | Cerebral edema (HP:0002181) | 3.55088173 |
| 17 | Microvesicular hepatic steatosis (HP:0001414) | 3.51380530 |
| 18 | Type I transferrin isoform profile (HP:0003642) | 3.44673501 |
| 19 | Lactic acidosis (HP:0003128) | 3.43664655 |
| 20 | Increased hepatocellular lipid droplets (HP:0006565) | 3.34672856 |
| 21 | Exercise intolerance (HP:0003546) | 3.34416552 |
| 22 | Lipid accumulation in hepatocytes (HP:0006561) | 3.28711193 |
| 23 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.28167405 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 3.26741390 |
| 25 | Increased serum lactate (HP:0002151) | 3.23122784 |
| 26 | Ragged-red muscle fibers (HP:0003200) | 3.20951167 |
| 27 | Abnormal gallbladder physiology (HP:0012438) | 3.04180732 |
| 28 | Cholecystitis (HP:0001082) | 3.04180732 |
| 29 | Reticulocytopenia (HP:0001896) | 2.99142075 |
| 30 | 3-Methylglutaconic aciduria (HP:0003535) | 2.93081841 |
| 31 | Respiratory failure (HP:0002878) | 2.92964228 |
| 32 | Progressive microcephaly (HP:0000253) | 2.87813145 |
| 33 | Emotional lability (HP:0000712) | 2.87456942 |
| 34 | Microretrognathia (HP:0000308) | 2.82763358 |
| 35 | Cerebral hypomyelination (HP:0006808) | 2.80982501 |
| 36 | Abnormality of glycolysis (HP:0004366) | 2.80510917 |
| 37 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.72084370 |
| 38 | Abnormal protein glycosylation (HP:0012346) | 2.69806474 |
| 39 | Abnormal glycosylation (HP:0012345) | 2.69806474 |
| 40 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.69806474 |
| 41 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.69806474 |
| 42 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.61837405 |
| 43 | Progressive muscle weakness (HP:0003323) | 2.60990275 |
| 44 | Macrocytic anemia (HP:0001972) | 2.58340532 |
| 45 | Hypertensive crisis (HP:0100735) | 2.56549844 |
| 46 | Myokymia (HP:0002411) | 2.55865366 |
| 47 | Broad distal phalanx of finger (HP:0009836) | 2.51849299 |
| 48 | Rough bone trabeculation (HP:0100670) | 2.47576351 |
| 49 | Cerebral palsy (HP:0100021) | 2.44715282 |
| 50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.43678758 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 2.43678758 |
| 52 | Increased serum pyruvate (HP:0003542) | 2.38600155 |
| 53 | Respiratory difficulties (HP:0002880) | 2.38437803 |
| 54 | Opisthotonus (HP:0002179) | 2.36933690 |
| 55 | Petechiae (HP:0000967) | 2.36525333 |
| 56 | Exertional dyspnea (HP:0002875) | 2.31063655 |
| 57 | Leukodystrophy (HP:0002415) | 2.29395846 |
| 58 | Aplastic anemia (HP:0001915) | 2.20915958 |
| 59 | Pancytopenia (HP:0001876) | 2.18199850 |
| 60 | Delusions (HP:0000746) | 2.14416722 |
| 61 | Pallor (HP:0000980) | 2.12516452 |
| 62 | Lethargy (HP:0001254) | 2.12073099 |
| 63 | Muscle fiber atrophy (HP:0100295) | 2.11088156 |
| 64 | Hyperthyroidism (HP:0000836) | 2.11072020 |
| 65 | Death in infancy (HP:0001522) | 2.10891965 |
| 66 | Myopathic facies (HP:0002058) | 2.09488070 |
| 67 | Spastic paraparesis (HP:0002313) | 2.07859126 |
| 68 | Reduced antithrombin III activity (HP:0001976) | 2.02095186 |
| 69 | Vertebral compression fractures (HP:0002953) | 2.00027488 |
| 70 | CNS demyelination (HP:0007305) | 1.99773147 |
| 71 | Multiple enchondromatosis (HP:0005701) | 1.99111835 |
| 72 | Optic disc pallor (HP:0000543) | 1.98979471 |
| 73 | Truncus arteriosus (HP:0001660) | 1.97126889 |
| 74 | Seborrheic dermatitis (HP:0001051) | 1.95962612 |
| 75 | Trismus (HP:0000211) | 1.94152519 |
| 76 | Rhabdomyolysis (HP:0003201) | 1.90593700 |
| 77 | Hepatosplenomegaly (HP:0001433) | 1.89974440 |
| 78 | Achilles tendon contracture (HP:0001771) | 1.88090634 |
| 79 | Abnormality of reticulocytes (HP:0004312) | 1.87091012 |
| 80 | Gliosis (HP:0002171) | 1.85327280 |
| 81 | Agammaglobulinemia (HP:0004432) | 1.84731661 |
| 82 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.82025380 |
| 83 | Obstructive lung disease (HP:0006536) | 1.79674846 |
| 84 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79674846 |
| 85 | Prolonged neonatal jaundice (HP:0006579) | 1.77900306 |
| 86 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.74628542 |
| 87 | Cleft eyelid (HP:0000625) | 1.72853800 |
| 88 | Abnormal trabecular bone morphology (HP:0100671) | 1.72430221 |
| 89 | Abnormality of the umbilical cord (HP:0010881) | 1.72230230 |
| 90 | Degeneration of anterior horn cells (HP:0002398) | 1.69471864 |
| 91 | Abnormality of the anterior horn cell (HP:0006802) | 1.69471864 |
| 92 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.67105735 |
| 93 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.66438793 |
| 94 | Cholelithiasis (HP:0001081) | 1.66181192 |
| 95 | Hypokinesia (HP:0002375) | 1.66010824 |
| 96 | Neoplasm of head and neck (HP:0012288) | 1.64630022 |
| 97 | Esophageal neoplasm (HP:0100751) | 1.64630022 |
| 98 | Growth hormone excess (HP:0000845) | 1.62524415 |
| 99 | Athetosis (HP:0002305) | 1.62293923 |
| 100 | CNS hypomyelination (HP:0003429) | 1.60892757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.63186465 |
| 2 | VRK2 | 4.95023076 |
| 3 | BCKDK | 3.56924468 |
| 4 | TESK2 | 3.42344275 |
| 5 | PIM2 | 2.83395241 |
| 6 | TESK1 | 2.78243492 |
| 7 | KDR | 2.71813643 |
| 8 | ARAF | 2.62001223 |
| 9 | MAP3K11 | 2.37033422 |
| 10 | BUB1 | 2.33799513 |
| 11 | TAOK2 | 2.04572331 |
| 12 | IRAK3 | 2.02088244 |
| 13 | SCYL2 | 1.90694098 |
| 14 | PRPF4B | 1.84633718 |
| 15 | TRIB3 | 1.81807456 |
| 16 | SMG1 | 1.67256444 |
| 17 | ERN1 | 1.64460689 |
| 18 | ABL2 | 1.53013728 |
| 19 | MAPKAPK3 | 1.49000281 |
| 20 | DAPK1 | 1.48715000 |
| 21 | VRK1 | 1.47848042 |
| 22 | ILK | 1.44352838 |
| 23 | PRKD3 | 1.31069371 |
| 24 | LIMK1 | 1.30792318 |
| 25 | NME1 | 1.30075219 |
| 26 | CDC7 | 1.28221540 |
| 27 | STK16 | 1.23403846 |
| 28 | AURKA | 1.23112735 |
| 29 | MUSK | 1.18274293 |
| 30 | CDK19 | 1.17858457 |
| 31 | BRAF | 1.16083744 |
| 32 | LRRK2 | 1.14361226 |
| 33 | TLK1 | 1.12948633 |
| 34 | GRK6 | 1.10107545 |
| 35 | DAPK3 | 1.06652486 |
| 36 | RPS6KB2 | 1.04022992 |
| 37 | CDK8 | 0.97770940 |
| 38 | RPS6KA5 | 0.92524201 |
| 39 | TBK1 | 0.91698014 |
| 40 | NEK1 | 0.89892378 |
| 41 | MAP4K1 | 0.89290063 |
| 42 | CSNK1G3 | 0.88355095 |
| 43 | PAK1 | 0.82450901 |
| 44 | PBK | 0.82271846 |
| 45 | SRPK1 | 0.82119117 |
| 46 | ZAK | 0.80058648 |
| 47 | EEF2K | 0.78227008 |
| 48 | MAP2K2 | 0.75667183 |
| 49 | DYRK2 | 0.73013308 |
| 50 | SIK1 | 0.72405461 |
| 51 | PRKCI | 0.72232680 |
| 52 | PAK4 | 0.70498938 |
| 53 | CCNB1 | 0.69722661 |
| 54 | CHEK2 | 0.67695746 |
| 55 | CDK7 | 0.66006999 |
| 56 | GRK5 | 0.60903252 |
| 57 | ATR | 0.60865561 |
| 58 | MAPKAPK5 | 0.60354592 |
| 59 | IKBKB | 0.59714751 |
| 60 | EPHA2 | 0.58375674 |
| 61 | TNK2 | 0.56284583 |
| 62 | CDK11A | 0.55732043 |
| 63 | CSNK1A1L | 0.55250844 |
| 64 | AURKB | 0.54061885 |
| 65 | CAMK2G | 0.52991266 |
| 66 | RAF1 | 0.51452820 |
| 67 | RPS6KA4 | 0.50513279 |
| 68 | CDK14 | 0.50372119 |
| 69 | CDK15 | 0.49085159 |
| 70 | MAP2K7 | 0.49076132 |
| 71 | MAP3K12 | 0.48727282 |
| 72 | MAP2K3 | 0.46230186 |
| 73 | IRAK2 | 0.45656652 |
| 74 | CDK18 | 0.44829969 |
| 75 | BRSK1 | 0.43863985 |
| 76 | CDK4 | 0.43341829 |
| 77 | CSNK2A2 | 0.43252756 |
| 78 | MAPK11 | 0.43146519 |
| 79 | PLK1 | 0.42227708 |
| 80 | CSNK1G2 | 0.41423515 |
| 81 | PDK2 | 0.41365494 |
| 82 | MAP3K8 | 0.39392827 |
| 83 | EIF2AK1 | 0.39370223 |
| 84 | CSNK2A1 | 0.39360089 |
| 85 | PAK6 | 0.38279111 |
| 86 | PKN1 | 0.37378919 |
| 87 | MAPK12 | 0.37193054 |
| 88 | DYRK3 | 0.34688831 |
| 89 | AKT2 | 0.31547596 |
| 90 | CSNK1G1 | 0.31496750 |
| 91 | FLT3 | 0.31451509 |
| 92 | PKN2 | 0.26777655 |
| 93 | MAP2K6 | 0.26711263 |
| 94 | PRKD2 | 0.26479338 |
| 95 | PDPK1 | 0.26247800 |
| 96 | SIK3 | 0.26088451 |
| 97 | NUAK1 | 0.24911691 |
| 98 | MINK1 | 0.23554619 |
| 99 | PIM1 | 0.23514252 |
| 100 | IRAK4 | 0.22937632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.67649363 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.00726098 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.75069736 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.62069739 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.57733483 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 3.46552179 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 3.23080167 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.59562655 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.54191943 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.53044603 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.38580570 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.34177670 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.29366317 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.11580692 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 1.99383900 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 1.94428142 |
| 17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.87313515 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.72465528 |
| 19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.72169241 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.65884543 |
| 21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.63267599 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55482710 |
| 23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.54380753 |
| 24 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.51362698 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.47320363 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.46709687 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.42133537 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40178181 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.36899626 |
| 30 | Purine metabolism_Homo sapiens_hsa00230 | 1.29869763 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.29284565 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27000846 |
| 33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.25035459 |
| 34 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.22926926 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.20666058 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19734450 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.13163166 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12234895 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99822907 |
| 40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.96733468 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.94991736 |
| 42 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.94741072 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92551755 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90715898 |
| 45 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.89432147 |
| 46 | RNA transport_Homo sapiens_hsa03013 | 0.87928067 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85088889 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83414464 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82607955 |
| 50 | Metabolic pathways_Homo sapiens_hsa01100 | 0.80562052 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79305214 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75691706 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67868543 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67317059 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64302913 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63714527 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63300423 |
| 58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62614391 |
| 59 | Protein export_Homo sapiens_hsa03060 | 0.61040163 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.60817980 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58233533 |
| 62 | RNA degradation_Homo sapiens_hsa03018 | 0.57783369 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.57579171 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57524081 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57469186 |
| 66 | Shigellosis_Homo sapiens_hsa05131 | 0.55162342 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54584868 |
| 68 | Cell cycle_Homo sapiens_hsa04110 | 0.51248077 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49824493 |
| 70 | Alcoholism_Homo sapiens_hsa05034 | 0.48009196 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47229897 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45860619 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.42289559 |
| 74 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40481096 |
| 75 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33794088 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32839330 |
| 77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.29501292 |
| 78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.25101451 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23723597 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22505331 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.18073269 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.17617876 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.15549994 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.15425903 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.15151704 |
| 86 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.14574264 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.14104699 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.11066978 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.10618139 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.09540390 |
| 91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.09167802 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.08822100 |
| 93 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.06583373 |
| 94 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.05889353 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.05757970 |
| 96 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.05198349 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.04304116 |
| 98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.04091105 |
| 99 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.03916219 |
| 100 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.03118707 |

